RIBC2
RIB43A-like with coiled-coils protein 2
Also known as: C22orf11, DKFZp566F0546, FLJ25720, RIBC2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H4K1
- Gene
- RIBC2
- Ensembl
- ENSG00000128408
- Chromosome
- 22
- Canonical length
- 382 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Perinuclear theca,Calyx,Connecting piece,Mid piece,Principal piece,End piece
OverviewNCBI Gene
Predicted to be involved in flagellated sperm motility. Located in axonemal microtubule. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
382 residues, UniProt reviewed canonical sequence.
>Q9H4K1|RIBC2
1 MGSQTMAVAL PRDLRQDANL AKRRHAELCR QKRVFNARNR IIGGDTEAWD VQVHDQKIKE
61 ATEKARHETF AAEMRQNDKI MCILENRKKR DRKNLCRAIN DFQQSFQKPE TRREFDLSDP
121 LALKKDLPAR QSDNDVRNTI SGMQKFMGED LNFHERKKFQ EEQNREWSLQ QQREWKNARA
181 EQKCAEALYT ETRLQFDETA KHLQKLESTT RKAVCASVKD FNKSQAIESV ERKKQEKKQE
241 QEDNLAEITN LLRGDLLSEN PQQAASSFGP HRVVPDRWKG MTQEQLEQIR LVQKQQIQEK
301 LRLQEEKRQR DLDWDRRRIQ GARATLLFER QQWRRQRDLR RALDSSNLSL AKEQHLQKKY
361 MNEVYTNQPT GDYFTQFNTG SRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RIBC2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- testis: 29 nTPM
- choroid plexus: 13 nTPM
- fallopian tube: 9.2 nTPM
- bone marrow: 1.8 nTPM
- pituitary gland: 1.3 nTPM
- basal ganglia: 1.2 nTPM
Single-cell type
- late primary spermatocytes: 382 nCPM
- early spermatids: 169 nCPM
- respiratory ciliated cells: 110 nCPM
- endometrial ciliated cells: 99 nCPM
- fallopian tube ciliated cells: 93 nCPM
- epididymal efferent duct ciliated cells: 90 nCPM
Immune cell
- myeloid DC: 0.3 nTPM
- memory CD8 T-cell: 0.2 nTPM
- T-reg: 0.2 nTPM
- classical monocyte: 0.1 nTPM
- memory B-cell: 0.1 nTPM
- naive CD8 T-cell: 0.1 nTPM
Brain region
- choroid plexus: 31 nTPM
- medulla oblongata: 6.1 nTPM
- midbrain: 6.1 nTPM
- white matter: 5.3 nTPM
- spinal cord: 3.8 nTPM
- amygdala: 2.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.48
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.37
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RIBC2 as an antibody target. Whether an autoantibody or antibody against RIBC2 could matter depends on whether native RIBC2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RIBC2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RIBC2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...